Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
by
Bashir, Bilal
, Soran, Handrean
, Durrington, Paul N.
in
Acetic acid
/ Aldehydes
/ antioxidant
/ Antioxidants
/ Apoptosis
/ Atherogenesis
/ Atherosclerosis
/ cardiovascular disease
/ Cell culture
/ Cell membranes
/ Cholesterol
/ Dextrose
/ Endothelium
/ Enzymes
/ Erythrocytes
/ Free radicals
/ Genetically modified organisms
/ Glucose
/ Hemoglobin
/ High density lipoprotein
/ Hydrogen peroxide
/ Hydrophobicity
/ Inflammation
/ LDL
/ Leukocyte migration
/ Leukocytes
/ lipid peroxidation
/ Lipoproteins
/ Liver
/ Low density lipoprotein
/ Low density lipoproteins
/ Metabolism
/ Metabolites
/ Monocytes
/ Mutation
/ Myocytes
/ Oxidation
/ Paraoxonase
/ Paraoxonase 1
/ paroxonase1
/ Pathogenesis
/ Peroxides
/ Physiological aspects
/ Proteins
/ Reactive oxygen species
/ Respiration
/ Review
/ Scavenger receptors
/ Tissue culture
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
by
Bashir, Bilal
, Soran, Handrean
, Durrington, Paul N.
in
Acetic acid
/ Aldehydes
/ antioxidant
/ Antioxidants
/ Apoptosis
/ Atherogenesis
/ Atherosclerosis
/ cardiovascular disease
/ Cell culture
/ Cell membranes
/ Cholesterol
/ Dextrose
/ Endothelium
/ Enzymes
/ Erythrocytes
/ Free radicals
/ Genetically modified organisms
/ Glucose
/ Hemoglobin
/ High density lipoprotein
/ Hydrogen peroxide
/ Hydrophobicity
/ Inflammation
/ LDL
/ Leukocyte migration
/ Leukocytes
/ lipid peroxidation
/ Lipoproteins
/ Liver
/ Low density lipoprotein
/ Low density lipoproteins
/ Metabolism
/ Metabolites
/ Monocytes
/ Mutation
/ Myocytes
/ Oxidation
/ Paraoxonase
/ Paraoxonase 1
/ paroxonase1
/ Pathogenesis
/ Peroxides
/ Physiological aspects
/ Proteins
/ Reactive oxygen species
/ Respiration
/ Review
/ Scavenger receptors
/ Tissue culture
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
by
Bashir, Bilal
, Soran, Handrean
, Durrington, Paul N.
in
Acetic acid
/ Aldehydes
/ antioxidant
/ Antioxidants
/ Apoptosis
/ Atherogenesis
/ Atherosclerosis
/ cardiovascular disease
/ Cell culture
/ Cell membranes
/ Cholesterol
/ Dextrose
/ Endothelium
/ Enzymes
/ Erythrocytes
/ Free radicals
/ Genetically modified organisms
/ Glucose
/ Hemoglobin
/ High density lipoprotein
/ Hydrogen peroxide
/ Hydrophobicity
/ Inflammation
/ LDL
/ Leukocyte migration
/ Leukocytes
/ lipid peroxidation
/ Lipoproteins
/ Liver
/ Low density lipoprotein
/ Low density lipoproteins
/ Metabolism
/ Metabolites
/ Monocytes
/ Mutation
/ Myocytes
/ Oxidation
/ Paraoxonase
/ Paraoxonase 1
/ paroxonase1
/ Pathogenesis
/ Peroxides
/ Physiological aspects
/ Proteins
/ Reactive oxygen species
/ Respiration
/ Review
/ Scavenger receptors
/ Tissue culture
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
Journal Article
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Low-density lipoprotein (LDL) chemically modified by reactive oxygen species (ROS), for example, leaking from red blood cells in the vascular compartment, more readily crosses the vascular endothelium than does nonoxidatively modified LDL to enter tissue fluid. Oxidatively modified LDL (oxLDL) may also be created in the tissue fluid by ROS leaking from cells by design, for example, by inflammatory white cells, or simply leaking from other cells as a consequence of oxygen metabolism. As well as oxLDL, glycatively modified LDL (glycLDL) is formed in the circulation. High-density lipoprotein (HDL) appears capable of decreasing the burden of lipid peroxides formed on LDL exposed to ROS or to glucose and its metabolites. The mechanism for this that has received the most attention is the antioxidant activity of HDL, which is due in large part to the presence of paraoxonase 1 (PON1). PON1 is intimately associated with its apolipoprotein A1 component and with HDL’s lipid domains into which lipid peroxides from LDL or cell membranes can be transferred. It is frequently overlooked that for PON1 to hydrolyze lipid substrates, it is essential that it remain by virtue of its hydrophobic amino acid sequences within a lipid micellar environment, for example, during its isolation from serum or genetically modified cells in tissue culture. Otherwise, it may retain its capacity to hydrolyze water-soluble substrates, such as phenyl acetate, whilst failing to hydrolyze more lipid-soluble molecules. OxLDL and probably glycLDL, once they have crossed the arterial endothelium by receptor-mediated transcytosis, are rapidly taken up by monocytes in a process that also involves scavenger receptors, leading to subendothelial foam cell formation. These are the precursors of atheroma, inducing more monocytes to cross the endothelium into the lesion and the proliferation and migration of myocytes present in the arterial wall into the developing lesion, where they transform into foam cells and fibroblasts. The atheroma progresses to have a central extracellular lake of cholesteryl ester following necrosis and apoptosis of foam cells with an overlying fibrous cap whilst continuing to grow concentrically around the arterial wall by a process involving oxLDL and glycLDL. Within the arterial wall, additional oxLDL is generated by ROS secreted by inflammatory cells and leakage from cells generally when couplet oxygen is reduced. PON1 is important for the mechanism by which HDL opposes atherogenesis, which may provide a better avenue of inquiry in the identification of vulnerable individuals and the provision of new therapies than have emerged from the emphasis placed on its role in RCT.
This website uses cookies to ensure you get the best experience on our website.